Ohio Scientists Develop Tiny Sensor to Diagnose Autism in Infants as Young as Two Months

Researchers at Ohio University have created a groundbreaking method to distinguish autism from intellectual disability within the first months of a baby's life. This innovation uses a nanoscale carbon fiber sensor combined with induced stem cells derived from patients' own cells, enabling early and objective diagnosis well before traditional behavioral signs emerge. Previously, doctors had to wait months or years, monitoring speech and behavior milestones to confirm diagnoses.

The challenge has been that autism and intellectual disability often show similar early behavioral symptoms and can stem from the same genetic mutations. Additionally, the blood-brain barrier prevents standard blood tests from revealing brain chemistry. To overcome this, scientists converted patients' cells into induced stem cells that reflect the brain's biochemical environment without interference from external factors like age or medication.

The nanosensor measures nitric oxide emissions from these stem cells, revealing distinct patterns: cells from individuals with intellectual disability emitted about 11 nanomolar (nM) of nitric oxide, autism cells emitted 6 nM, and healthy controls emitted 65 nM. This clear biochemical difference allows immediate differentiation even when genetic mutations are identical.

Howard D. Debald, a co-researcher, highlighted the simplicity and speed of the method, noting that measurements were made directly on basic stem cells without needing to mature them into neurons. Another researcher, Abdallah Asif Khan, emphasized that this real-time chemical analysis could provide definitive early diagnosis, enabling families to begin targeted therapies and interventions much earlier than currently possible.

Published in the journal NeuroMarkers and by KeAI Communications, this research marks a significant advance toward personalized medicine. While based on a small initial cell sample, the model can potentially extend to diagnosing various brain disorders. Replacing prolonged behavioral observation with a laboratory test could transform developmental outcomes for children worldwide.